MPM BioImpact related stories
All articles and analysis
Haynes & Boone's fund financing report in six chartsSub line margins rose 17% last year as fund financing becomes more lender-friendly, according to Haynes & Boone’s Fund Finance Annual Report 2023.
Fund finance market still reeling from US bank collapsesPrivate markets CFOs are navigating a fund finance market in flux in the wake of the regional banking crisis.
St. Peter steps down from MPM CapitalSteven St. Peter, who worked at Carlyle and Apax, has stepped down as a managing director at life sciences firm MPM Capital to focus on his next move in the venture industry.
- Fisher Lynch bolsters IR, legal teams
The firm has added director of investor relations Kristie Goodman and director of administration and legal affairs Dana O’Brien, both newly created positions.
- NEA hires former XM Radio chief
Hugh Panero, former chief executive of the satellite radio company, is the latest in a string of high-profile appointments the Maryland-based venture firm has made over the last year.
- NEA boosts ‘venture growth’ team with two hires
Silicon Valley-based New Enterprise Associates has recruited Morgan Stanley's Tony Florence and MPM Capital's Paul Walker to bolster its large-scale investment team.
- Consortium invests $145m in specialty pharma
MPM Capital and LLR Partners have led a Series D financing round totaling $50 million in equity and $95 million in debt for acute-care company EKR Therapeutics.
- CalPERS makes $718m in commitments
The $253 billion California pension fund made a fresh round of commitments to record-setting healthcare- and life science-focussed VC funds in addition to CVC and KKR.
- Third Rock closes debut fund on $378m(3)
Newly formed venture firm Third Rock Ventures will use its first fund for investments in early stage biotechnology companies.
- Third Rock closes debut fund on $378m(2)
Newly formed venture firm Third Rock Ventures will use its first fund for investments in early stage biotechnology companies.